Glioblastoma patients' survival and its relevant risk factors during the pre- and post-COVID-19 pandemic: Real-world cohort study in the USA and China
Description
CONCLUSIONS: As the timeframe shifted from pre- to post-COVID-19 pandemic, survival of GBM patients remained stable, yet advanced age, bilateral tumors, and passive treatment continuingly impacted GBM survival. It is necessary to optimize the